CVB homepage

VIDEO: Arnold Seto, MD, MPA, FSCAI, Cath Lab Director, VA Long Beach Healthcare System, Long Beach, professor of medicine at Charles Drew University, and the Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and and chair of the advocacy committee, explains SCAI's change in position on TAVR after listening to what members had to say in a survey.

SCAI surveyed its members to find out what they thought about potential changes to current TAVR policies. The responses to that survey helped influence the group's official stance. 

Firefighters during a training structure fire at Monroe Fire School in Wisconsin. Photo by Dave Fornell

These findings call into question the types of screenings firefighters should undergo to detect potential heart problems.

The upcoming Society of Thoracic Surgeons annual meeting in San Diego is scheduled to feature multiple big-name speakers. The four-day event runs Jan. 28-31, 2027. 

Arnold Seto, MD, MPA, FSCAI, Cath Lab Director, VA Long Beach Healthcare System, Long Beach, professor of medicine at Charles Drew University, and the Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and and chair of the advocacy committee, explains how interventional cardiology is undergoing a transition to pre-planning percutaneous coronary interventions (PCI) using CT can information rather than than making decisions on the fly and making best guesses on device sizings. #YesCCT

CCTA offers clinicians an opportunity to make patient care more efficient. However, interventionalists need to make sure they understand how to properly interpret coronary CT data.

Biotronik has received the FDA’s breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS) for patients with chronic limb-threatening ischemia (CLTI).

The Freesolve Resorbable Magnesium Scaffold previously received the same designation for below-the-knee interventions. This update covers minimally invasive coronary procedures.

Cardiac arrest still occurs during nearly 1% of all PCI procedures. It is most common during acute coronary syndrome interventions.

Innovation at work

Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.

Sponsored by Philips Healthcare